GEN1079
/ Genmab
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 26, 2026
GCT1079-01: Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants with Advanced Solid Tumors
(clinicaltrialsregister.eu)
- P1 | N=77 | Not yet recruiting | Sponsor: Genmab A/S
New P1 trial • Oncology • Solid Tumor
February 20, 2026
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid Tumors
(clinicaltrials.gov)
- P1 | N=121 | Recruiting | Sponsor: Genmab | Not yet recruiting ➔ Recruiting
Enrollment open • First-in-human • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1